alexa

GET THE APP

Targeting the <em>andalpha;</em> 4 <em>andbeta;</em> 2- and <em>andalpha;</em> 7-Subtypes of Nicotinic Acetylcholine Receptors for Smoking Cessation Medication Development| Abstract
ISSN: 2155-6105

Journal of Addiction Research & Therapy
Open Access

Like us on:

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
  • Review Article   
  • J Addict Res Ther 2019, Vol 10(2): 381
  • DOI: 10.4172/2155-6105.1000381

Targeting the α 4 β 2- and α 7-Subtypes of Nicotinic Acetylcholine Receptors for Smoking Cessation Medication Development

Lakshmi Ramachandran Nair and Xiu Liu*
Department of Pathology, University of Mississippi Medical Center, Jackson, MS 39216, USA
*Corresponding Author : Xiu Liu, Department of Pathology, University of Mississippi Medical Center, Jackson, MS 39216, USA, Tel: +1(601) 984-2875, Email: [email protected]

Received Date: Jan 21, 2019 / Accepted Date: Apr 08, 2019 / Published Date: Apr 15, 2019

Abstract

Nicotine exerts its reinforcing actions via activating the nicotinic acetylcholine receptors (nAChRs). Among an increasing number of nAChR subtypes, the α4β2 and α7 nAChRs are the two major ones, accounting for about 95% of the whole nAChR population in brain. Research findings from our own laboratory, together with other reports in the field, suggest critical and differential involvement of the α4β2 and α7 nAChRs in the process of nicotine dependence and tobacco addiction. Specifically, rat models of nicotine consumption and cue-induced relapse were used to examine the effects of selective antagonism of these two nAChR subtypes on the primary reinforcement of nicotine and the conditioned reinforcing actions of nicotine-associated environmental stimuli (cues). Results demonstrated that blockade of the α4β2 but not α7 subtype effectively reduced nicotine intake, whereas α7 but not α4β2 nAChR blockade reversed cue-triggered nicotine relapse behavior. These findings lend support for the continued effort to develop cholinergic agents aiming at the α4β2 nAChRs for reducing or stopping smoking. However, it is suggested that manipulation of α7 nAChR activity would be a promising target for preventing smoking relapse triggered by exposure to environmental cues.

Keywords: Conditioned stimuli (cues); Nicotinic acetylcholine receptors (nachrs); Reinforcing actions; Relapse; Self-administration

Citation: Nair LR, Liu X (2019) Targeting the α4β2- and α7-Subtypes of Nicotinic Acetylcholine Receptors for Smoking Cessation Medication Development. J Addict Res Ther 10:381. Doi: 10.4172/2155-6105.1000381

Copyright: © 2019 Nair LR, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution and reproduction in any medium, provided the original author and source are credited.

Select your language of interest to view the total content in your interested language

Post Your Comment Citation
Share This Article
Recommended Conferences
Article Usage
  • Total views: 834
  • [From(publication date): 0-0 - Sep 28, 2021]
  • Breakdown by view type
  • HTML page views: 651
  • PDF downloads: 183
Top